New research presented at ASM Microbe 2026 identifies a critical link between gut microbes, bile acids, and cardiovascular complications in sleep apnea patients. According to the American Society for Microbiology, targeting the farnesoid X receptor (FXR) may offer a new path for preventing heart and metabolic damage caused by the disorder, which affects millions worldwide.
How do gut microbes influence sleep apnea heart risks?
Obstructive sleep apnea causes repeated breathing interruptions, leading to oxygen deprivation and carbon dioxide buildup. Research led by Celeste Allaband, DVM, Ph.D., at the University of California, San Diego, suggests that these physiological stressors alter bile acids. These compounds, produced by the liver and stored in the gallbladder, serve as chemical messengers that bind to receptors throughout the body. When modified by gut microbes, these bile acids can influence the development of fatty plaques in the heart, a process known as atherosclerosis.
Bile acids do more than digest fats. They act as essential signaling molecules that interact with receptors to regulate various physiological processes, including the formation of arterial plaques.
What happens when the FXR receptor is blocked?
To understand the role of bile acid signaling, researchers compared heart-disease-prone mice (ApoE knock-outs) with a group that also lacked the farnesoid X receptor (ApoE/FXR knock-outs). According to the American Society for Microbiology, removing the FXR receptor significantly reduced the buildup of arterial plaques in the aorta and aortic arch during sleep apnea-like conditions. Furthermore, the absence of this receptor helped protect the gut microbiome and metabolome from the disruptions typically caused by the sleep disorder.
“Our study shows that the FXR host receptor, which can be activated or deactivated by bile acids, plays a central role in driving the buildup of fatty plaques in the arteries during sleep apnea-like conditions,” Allaband said.
What are the next steps for clinical treatment?
The research team is now looking to translate these findings into human applications. Future studies will examine human datasets to confirm if the same bile acid-driven trends exist in patients. Dr. Allaband noted that the team is exploring the potential of using specific bile acid supplements or targeted probiotics to prevent or reduce disease progression. By identifying the exact microbes and metabolites involved, researchers hope to move toward preventative care strategies for those suffering from sleep apnea.
Frequently Asked Questions
- What is the connection between sleep apnea and heart health?
Sleep apnea causes oxygen deprivation, which alters bile acid composition. These changes can promote the buildup of fatty plaques in the arteries, increasing cardiovascular risk. - What is the farnesoid X receptor (FXR)?
FXR is a host receptor that interacts with bile acids. Researchers found it plays a central role in driving arterial plaque development under sleep apnea conditions. - Can probiotics help with sleep apnea?
Researchers are investigating whether specific microbes could be administered as probiotics to mitigate the metabolic and heart-related impacts of sleep apnea.
Keep an eye on upcoming clinical trials related to microbiome therapeutics. As researchers identify specific metabolites that influence cardiovascular health, personalized nutrition and probiotic interventions may become standard components of chronic disease management.
Have you or someone you know been diagnosed with sleep apnea? Join the conversation in the comments below or subscribe to our newsletter for the latest updates on microbial research and cardiovascular health.
